Immuneering (IMRX) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
Immuneering insider trading at a glance (Oct 9, 2026): in the past 12 months, 6 insiders bought $270K and 0 sold $0 of IMRX stock on the open market, including a cluster buy that began Jan 12, 2026.
Get emailed when insiders cluster-buy stocks like IMRX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
IMRX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | $36K | 2 | — | 0 |
| Q1 2026 | $234K | 5 | — | 0 |
| Q4 2025 | $64K | 4 | — | 0 |
| Q3 2025 | $53K | 1 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 6 Immuneering Corp insiders reported open-market purchases totaling $270K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Jan 12, 2026, when 5 insiders bought a combined $234K. Among insiders with enough purchase history to measure, Peter Feinberg (Director) has the highest Insider Score at 69.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jun 24SEC | Benjamin J. ZeskindCEO, President | Buy | 2,4002,315,252 held (+0%) | $4.56 | $11K | -13.6% | — |
| Jun 16SEC | Brett Matthew HallChief Scientific Officer | Buy | 6,035382,531 held (+2%) | $4.15 | $25K | -5.1% | 69 |
| Jan 21SEC | Harold Eugene BrakewoodChief Business Officer | Buy | 5,25011,050 held (+91%) | $4.76 | $25K | -17.2% | — |
| Jan 20SEC | Thomas J. SchallDirector | Buy | 21,64574,530 held (+41%) | $4.67 | $101K | -15.6% | — |
| Jan 16SEC | Brett Matthew HallChief Scientific Officer | Buy | 2,298376,496 held (+1%) | $4.57 | $11K | -13.8% | 69 |
| Jan 15SEC | Leah R NeufeldChief People Officer | Buy | 2,62625,970 held (+11%) | $4.15 | $11K | -5.1% | — |
| Jan 14SEC | Peter FeinbergDirector | Buy | 20,000135,441 held (+17%) | $4.35 | $87K | -9.4% | 69 |
| Oct 7SEC | Peter FeinbergDirector | Buy | 7,500156,766 held (+5%) | $6.67 | $50K | -40.9% | 69 |
| Oct 2SEC | Michael BookmanGeneral Counsel | Buy | 1,0204,870 held (+26%) | $6.83 | $7K | -42.3% | — |
| Oct 2SEC | Leah R NeufeldChief People Officer | Buy | 80023,344 held (+4%) | $6.38 | $5K | -38.2% | — |
| Oct 2SEC | Mallory MoralesChief Accounting Officer | Buy | 30027,533 held (+1%) | $6.39 | $2K | -38.3% | — |
| Oct 1SEC | Peter FeinbergDirector | Buy | 7,500149,266 held (+5%) | $7.03 | $53K | -44.0% | 69 |
Insiders at Immuneering Corp
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Peter FeinbergDirector | $190K | — | Jan 14, 2026 | 69 |
| Thomas J. SchallDirector | $101K | — | Jan 20, 2026 | — |
| Brett Matthew HallChief Scientific Officer | $36K | — | Jun 16, 2026 | 69 |
| Harold Eugene BrakewoodChief Business Officer | $25K | — | Jan 21, 2026 | — |
| Leah R NeufeldChief People Officer | $16K | — | Jan 15, 2026 | — |
| Benjamin J. ZeskindCEO, President | $11K | — | Jun 24, 2026 | — |
| Michael BookmanGeneral Counsel | $7K | — | Oct 2, 2025 | — |
| Mallory MoralesChief Accounting Officer | $2K | — | Oct 2, 2025 | — |
IMRX stock: common questions
Are Immuneering Corp insiders buying IMRX stock?
In the past 12 months, 6 insiders reported open-market purchases of IMRX worth $270K. The latest was CEO, President Benjamin J. Zeskind bought $11K of IMRX at $4.56 — first open-market purchase in our records.
Are Immuneering Corp insiders selling IMRX stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is IMRX's 52-week range?
Over the past year IMRX has traded between $3.74 and $8.33. It last closed at $3.94 on Oct 9, 2026.